Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer.

Naheed Arfin Borah, Mamatha M Reddy

Molecules (Basel, Switzerland) 2021 Apr 01

filter terms:

Aurora kinase B (AURKB) is a mitotic serine/threonine protein kinase that belongs to the aurora kinase family along with aurora kinase A (AURKA) and aurora kinase C (AURKC). AURKB is a member of the chromosomal passenger protein complex and plays a role in cell cycle progression. Deregulation of AURKB is observed in several tumors and its overexpression is frequently linked to tumor cell invasion, metastasis and drug resistance. AURKB has emerged as an attractive drug target leading to the development of small molecule inhibitors. This review summarizes recent findings pertaining to the role of AURKB in tumor development, therapy related drug resistance, and its inhibition as a potential therapeutic strategy for cancer. We discuss AURKB inhibitors that are in preclinical and clinical development and combination studies of AURKB inhibition with other therapeutic strategies.

Citation

Naheed Arfin Borah, Mamatha M Reddy. Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer. Molecules (Basel, Switzerland). 2021 Apr 01;26(7)